logo
Send Message
Hefei Home Sunshine Pharmaceutical Technology Co.,Ltd
products
products
Home > products > Chemical Intermediates > 3'-Chloropropiophenone CAS 34841-35-5

3'-Chloropropiophenone CAS 34841-35-5

Product Details

Place of Origin: China

Brand Name: Sunshine

Certification: ISO,COA

Model Number: 34841-35-5

Payment & Shipping Terms

Minimum Order Quantity: Negotiation

Price: Negotiation

Packaging Details: Aluminum Foil Bag, Drum

Delivery Time: 7-15 days

Payment Terms: T/T, L/C, D/A, Western Union

Supply Ability: TON

Get Best Price
Highlight:
CAS NO::
34841-35-5
Appearance ::
White To Grey To Yellow Crystalline Solid
Molecular Formula::
C9H9ClO
Molecular Weight::
168.62
EINECS NO::
252-242-3
MDL NO::
MFCD00009925
CAS NO::
34841-35-5
Appearance ::
White To Grey To Yellow Crystalline Solid
Molecular Formula::
C9H9ClO
Molecular Weight::
168.62
EINECS NO::
252-242-3
MDL NO::
MFCD00009925
3'-Chloropropiophenone CAS 34841-35-5

Product Description:

Product Name: 3'-Chloropropiophenone CAS 34841-35-5

 

 

 

 

 

 

Synonyms:

3-Chlorophenyl Ethyl Ketone;

3'-chlorophenyl propanone;

3′-Chloropropiophenone;

1-(3-Chlorophenyl)propan-1-one;

3‘-Chloropropiophenone;

m-Chlorophenylacetone;

3'-chloro propiophenone;

m-chloro-propiophenone;

 

 

 

 

 

 

Chemical & Physical Properties:

Appearance : White to grey to yellow crystalline solid

Assay :≥98.0%

Density:1.1 28g/cm3

Boiling Point:246.8 °C at 760 mmHg

Flash Point:122.7 °C

Melting Point: 43-47℃

Stability: Stable under normal temperatures and pressures.

 

 

 

 

 

 

 

3-chlorophenylacetone is the key intermediate for the synthesis of bupropion hydrochloride, dapoxeti ne and malavero. Bupropion is a kind of antidepressant. It is a kind of blocker for weak neurons to absorb 5-hydroxytryptamine and adrenaline. It is suitable for patients with other depression drugs whose therapeutic effect is not clear or can not tolerate depression. At the same time, bupropion can also be used as an auxiliary treatment for smoking cessation, virus infection or sexu al dysfunction.

Maraviroc was developed by Pfizer and approved by FDA on August 6, 2007. Malavero is a CCR5 receptor antagonist. CCR5 receptor is the only way of HIV infection. Therefore, it can be used as a broad-spectrum anti HIV drug, which is used in combination with other anti retroviral drugs to treat adult HIV-1 infection.

 

 

 

 

 

 

If you are interested in our products or have any questions, please feel free to contact us!

 

 

 

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.